Get the app
US › Healthcare

Indaptus Therapeutics Inc (INDP)

US · Healthcare · Biotechnology

$2.63-7.72%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-1.8M
EPS
$-0.02

Key statistics

Market cap
$318.4M
Forward P/E
0.0
P/B
44.17
Book value
$0.09
EPS (TTM)
$-6.15
52-week high
$5.96
52-week low
$0.92
50-day MA
$2.04
200-day MA
$2.28
Beta
0.97

Analyst view

with an average price target of $10.00.

Shareholding

Insiders
82.41%
Institutions
0.30%

Largest institutional holders

FundStake
HRT FINANCIAL LLC0.15%
Geode Capital Management, LLC0.04%
Jane Street Group LLC0.04%
Vanguard Capital Management, LLC0.03%
Vanguard Fiduciary Trust Co0.01%
Millennium Management LLC0.01%
Morgan Stanley - Brokerage Accounts0.01%
UBS Group AG0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Indaptus Therapeutics Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.